Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Goldman-Backed Biotech Attovia Raises $289 Million in US IPO

Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at bloomberg.com →

More in Finance & Markets

More from Wednesday 5 August →